References
Shinko D, Diakos CI, Clarke SJ, Charles KA. Cancer-related systemic inflammation: the challenges and therapeutic opportunities for personalized medicine. Clin Pharmacol Ther. 2017;102:599–610.
Rossi S, Basso M, Strippoli A, et al. Are markers of systemic inflammation good prognostic indicators in colorectal cancer? Clin Colorectal Cancer. 2017;16:264–74.
Suzuki S, Akiyoshi T, Oba K, et al. Comprehensive comparative analysis of the prognostic value of systemic inflammatory biomarkers for patients with stage II/III colon cancer. Ann Surg Oncol. 2019. https://doi.org/10.1245/s10434-019-07904-9.
Pagès F, Mlecnik B, Marliot F, et al. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet. 2018;391:2128–39.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors have no conflict of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This ASO Author Reflections is a brief invited commentary on the article, “Comprehensive Comparative Analysis of the Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer,” Ann Surg Oncol. (2019). https://doi.org/10.1245/s10434-019-07904-9.
Rights and permissions
About this article
Cite this article
Suzuki, S., Akiyoshi, T. ASO Author Reflections: Comparison of Prognostic Impact of Various Systemic Inflammatory Markers for Stage II/III Colon Cancer. Ann Surg Oncol 27, 853–854 (2020). https://doi.org/10.1245/s10434-019-08019-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-019-08019-x